Traumatic Brain Injury or TBI is sustained from severe or mild damage to the brain tissue from accidents or assaults. In North America, over 1.7 million people suffer annually from TBI and the consequent medical care costs exceed USD 70 billion. According to WHO, the global incidence for TBI is close to 10 million people annually. Brain tissue has one of the least self-repair capabilities making it highly vulnerable to injuries and often leading to permanent loss or disability of motor functions which dramatically reduces the quality of life for any individual. Most neuronal damage occurs sometime after the injury takes place giving a chance for a therapeutic intervention. The previous intervention with Glucocorticoids is not considered due to their harmful effects. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/5744 A major challenge in developing therapeutics for TBI lie in overcoming the blood-brain barrier while delivering drugs. In M
Focus on providing precise information and statistics based on the requirements of Business Person is relentless.